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Genotypic discrepancies arising from imputation
Anthony L Hinrichs1*, Robert C Culverhouse2, Brian K Suarez1,3
From Genetic Analysis Workshop 18
Stevenson, WA, USA. 13-17 October 2012

Abstract
The ideal genetic analysis of family data would include whole genome sequence on all family members. A strategy
of combining sequence data from a subset of key individuals with inexpensive, genome-wide association study
(GWAS) chip genotypes on all individuals to infer sequence level genotypes throughout the families has been
suggested as a highly accurate alternative. This strategy was followed by the Genetic Analysis Workshop 18 data
providers. We examined the quality of the imputation to identify potential consequences of this strategy by
comparing discrepancies between GWAS genotype calls and imputed calls for the same variants. Overall, the
inference and imputation process worked very well. However, we find that discrepancies occurred at an increased
rate when imputation was used to infer missing data in sequenced individuals. Although this may be an artifact of
this particular instantiation of these analytic methods, there may be general genetic or algorithmic reasons to
avoid trying to fill in missing sequence data. This is especially true given the risk of false positives and reduction in
power for family-based transmission tests when founders are incorrectly imputed as heterozygotes. Finally, we note
a higher rate of discrepancies when unsequenced individuals are inferred using sequenced individuals from other
pedigrees drawn from the same admixed population.
Background
The ideal genetic analysis of family data would include
whole genome sequence data on all family members. To
save cost, a procedure has been suggested to avoid having
to sequence every individual [1]. In particular, this procedure uses dense sequence data on a subset of individuals
and sparse, inexpensive, genome-wide association study
(GWAS) chip genotypes on all individuals to infer
sequence-level genotypes on the related, unsequenced
individuals. The Genetic Analysis Workshop 18 (GAW18)
data providers have followed these procedures as documented in [2]. We examine the quality of the imputation
to identify potential consequences for this approach.
Methods
The data

The GAW18 data providers obtained family data from
two studies: the San Antonio Family Heart Study and
the San Antonio Family Diabetes/Gallbladder Study [3].
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The GAW18 data set contains GWAS chip genotypes
on 959 individuals from 20 pedigrees. Of this sample, a
subset of 464 individuals also has whole genome
sequence data. Although four families have no
sequenced individuals, the remaining pedigrees are
sequenced for roughly half of their members (Table 1).
Generation of the data by the GAW18 providers

We will distinguish between two ways that missing data
were “filled in” in the GAW18 data: filling in missing
sequence data in the sequenced individuals will be
referred to as “imputation,” and inferring sequence-level
data for individuals who were only genotyped using a
GWAS chip will be referred to as “inference.” We
understand the imputation and inference process followed by the GAW18 data providers to consist of the
following steps: (a) the GWAS chip data were phased
(and any untyped GWAS chip alleles imputed) using
MaCH [4], and a haplotype scaffolding for the families
was created; (b) missing sequence data in the sequenced
individuals were imputed using MaCH; (c) sequence
haplotypes for the unsequenced individuals were
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Table 1 Discrepancies by family
Sequenced individuals
Fam_ID

N

D

Nonsequenced individuals
D/N

All individuals

N

D

D/N

N

D

D/N

T2DG23

32

14678

458.7

32

14678

458.7

T2DG15

41

17431

425.1

41

17431

425.1

T2DG14

40

15459

386.5

40

15459

386.5

T2DG25

33

12714

385.3

33

12714

385.3
260.1

T2DG17

20

5287

264.4

22

5639

256.3

42

10926

T2DG20

20

4977

248.9

16

2943

183.9

36

7920

220.0

T2DG08
T2DG27

25
17

5461
3686

218.4
216.8

43
18

9112
3074

211.9
170.8

68
35

14573
6760

214.3
193.1

T2DG02

43

9108

211.8

43

7922

184.2

86

17030

198.0

T2DG21

19

3915

206.1

16

2630

164.4

35

6545

187.0

T2DG04

38

7245

190.7

25

4155

166.2

63

11400

181.0

T2DG06

39

6976

178.9

25

3174

127.0

64

10150

158.6

T2DG03

38

4675

123.0

39

6943

178.0

77

11618

150.9

T2DG11

29

5132

177.0

6

774

129.0

35

5906

168.7

T2DG10
T2DG16

40
26

5127
3211

128.2
123.5

24
22

4058
3434

169.1
156.1

64
48

9185
6645

143.5
138.4

T2DG47

12

1785

148.8

10

1547

154.7

22

3332

151.5

T2DG09

27

3182

117.9

6

878

146.3

33

4060

123.0

T2DG07

30

3378

112.6

6

867

144.5

36

4245

117.9

T2DG05

40

4349

108.7

28

3058

109.2

68

7407

108.9

Discrepancies in the full comparison single-nucleotide polymorphisms set between GWAS data and GENO data sets, by family, individuals sequenced and
individuals imputed. Bold indicates highest discrepancy rate by subsample.
N=number of individuals in the family
D=number of discrepancies observed within the family
D/N=average number of discrepancies observed per family

inferred from the sequenced individuals using haplotype
scaffolding derived from the GWAS chip data;
(d) SimWalk2 was used to identify Mendelian errors and
blank inconsistent genotypes; and (e) Merlin [5] was used
to reimpute missing genotypes. The GAW18 data providers supplied a dosage file for each sequence variant. They
did not provide other quality scores for the imputation
and inference.
Selection of single-nucleotide polymorphisms and
individuals for discrepancy evaluation

The sequence data were provided in “VCF” (Variant Call
Format) files. Starting with the 8,348,685 single-nucleotide polymorphisms (SNPs) that made it through quality
control to end up in the final genotyping files [2], we
used the VCF files to find uniquely occurring rs numbers from dbSNP that mapped to an existing SNP in the
GWAS sample. The SNPs were required to map to the
same chromosome and have alleles that could be
“flipped” to align the strands; that is, a SNP of the type
A/C in GWAS and T/G in sequencing could be aligned,
but a SNP of the type A/C could not be aligned with an
A/G SNP. Furthermore, because the A/T and C/G polymorphisms could have ambiguous alignment, these were
discarded before comparisons were performed. Overall,

this resulted in 451,279 SNPs for comparison. We will
call these SNPs the “full comparison SNPs.”
We compared two data sets containing these 451,279
SNPs: first, the “GENO” data set (the final, cleaned,
sequence) and second, the “GWAS” data set (as provided, assembled from three different GWAS chips [2]).
Because of varying call rates, we did not count missing
genotypes as discrepancies between the two files (i.e., a
discrepancy was noted only when a genotype was present [i.e., called] in both data sets but was not identical).
We identified one strong outlier: sequenced individual
T2DG0400247 contained 11,576 discrepancies across
the 451,279 SNPs. The next most discrepant individual
had “only” 1880 discrepancies. The sample for individual
T2DG0400247 may have somehow changed between the
GWAS and the sequencing, perhaps because of a sample
swap or contamination. This individual was removed
from all of our subsequent analyses, leaving 958 individuals with GWAS data and 463 individuals with whole
genome sequencing.
Genotyping for the GWAS was performed on several
different Illumina platforms, resulting in a range of
missing rates (because of different SNPs on the platforms). The SNPs called from sequencing also had a
high variability in missing rate. Therefore, to have a
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frame of reference that avoids focusing on the GWAS
genotyping process or sequencing process per se, we
identified a subset of SNPs with a 98% or better call
rate for both GWAS and sequencing. There were
235,549 SNPs in the “high call rate” set.
Evaluation of discrepancies

We then examined discrepancies in four ways to help
identify causes of discrepancy: by individual, by presence
or absence of sequence data, by family, and by allele
dosage estimate. We also divided the discrepancies by analytical process: imputation (filling in missing genotypes in
sequenced individuals) and inference (inferring sequence
level data for individuals without sequencing). In the
sequenced individuals, imputed genotypes were determined by comparing the VCF (sequencing reads) file with
the final genotype calls file, GENO. Genotypes that were
missing in the VCF file for a sequenced individual but
present in the GENO file were, by definition, imputed.

Results
We first present the results for the high call rate SNPs
alone and then compare these with the results found in
the full comparison SNPs set. In both cases, we look at
the rate of discrepancies between the GWAS file (based
on a genotype chip) and the GENO file (genotype calls
based on sequence, imputation, or inference).
Discrepancy rate for the high call rate single-nucleotide
polymorphisms
Overall discrepancy rate

The overall discrepancy rate combined across
sequenced, imputed and inferred genotype calls for this
SNP set was low (Table 2). For this broadest group of
subjects (958 individuals) in the high call rate SNPs
(235,549 SNPs), calls were present in both the GWAS
and the GENO data sets 99.46% of the time. Of these,
197,984 were discrepant (0.09%) for an overall concordance rate of 99.91%. There were no discrepancies at all
for 68.6% (N = 161,573) of these SNPs.

Discrepancies in the sequenced individuals

However, looking at discrepancy rate by call process
yields a very different picture. As indicated in Table 2,
when we compare the sequence calls with the GWAS
chip calls in the 463 sequenced individual, we see a low
discrepancy rate (0.03%). This accounted for the vast
majority of the genotype calls for these individuals
(99.8%). Imputation was used to fill in many of the
missing calls in the sequenced individuals. The 0.2% of
the genotype calls for these high call rate SNPs generated by imputation yielded a surprisingly high discrepancy rate of 25.2%. An analysis of these discrepancies
yields some interesting results. This high discrepancy
rate occurred even though the number of imputed individuals for any given SNP was very low (at most 9 of
the 463 individuals). Also, the majority of these discrepancies (98.6%) consisted of a homozygote call from the
GWAS chip and a heterozygote call from the imputation. We believe that all imputed genotype calls
included in the GENO file were nonambiguous. This is
based on the data description (which states that likely
imputation errors were left blank) combined with our
observation that all genotypes with nonintegral dosage
values (e.g., dosage = 0.001 or 0.999), as well as many
additional genotypes with integral dosage values, were
blank in the GENO file.
Discrepancies in the nonsequenced individuals

Not surprisingly, we see higher discrepancy rates in
individuals whose sequences were inferred than in the
sequenced individuals themselves. Having no sequenced
family members clearly degraded the process further:
the discrepancy rate for inferred individuals without
genotyped family members was approximately twice the
rate of discrepancies found in individuals with
sequenced family members (Table 2, final two rows).
Discrepancy rate for the full comparison single-nucleotide
polymorphisms

As would be expected, when we expand beyond the high
call rate SNPs, the discrepancy rate increases.

Table 2 Discrepancies by process type
Discrepancy

High call rate SNPs
(98% call rate) 235,549 SNPs

Full comparison SNPs 451,279 SNPs

Type

Subjects

Genotypes (N)

% Discrepant

Genotypes (N)

% Discrepant

Imputation

463

205,962

25.16

1,864,804

28.82

Sequencing

463

107,780,325

0.03

197,178,315

0.06

Inference

495

116,463,033

0.10

222,926,764

0.20

Inference
Families with sequence

349

82,103,861

0.07

157,186,202

0.18

Inference
Families without sequence

146

34,359,172

0.18

65,740,562

0.26

Discrepancies between genome-wide association study (GWAS) data and GENO data sets, divided by analytical process. “Imputation” fills in missing genotypes in
sequence data. “Inference” infers phased sequence data on unsequenced individuals based on GWAS data. SNP, single-nucleotide polymorphism.
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Overall discrepancy rate

The overall discrepancy rate combined across sequenced,
imputed, and inferred genotype calls across the full
comparison SNPs was also low (see Tables 1 and 2). In
this group (958 individuals with 451,279 SNPs, for roughly
432 million potential calls), calls were present in both the
GWAS and the GENO data sets 97.6% of the time. Of
these, slightly more than 1 million (1,099,402) were discrepant (0.26%), for an overall concordance rate of 99.74%.
We note that a small number of these SNPs (fewer than
60) were outliers with an unusually high number of discrepancies. (Two SNPs had more than 900 discrepancies, and
8 SNPs had more than 800 discrepancies. These are likely
to have been cases in which the sequenced SNP was not
the SNP genotyped on the GWAS. None of these SNPs
were in the high call rate SNPs. In the full sample, excluding these SNPs results in a slight decrease in discrepancies
in the second decimal place [results not shown].)
Discrepancies in the sequenced individuals

As was seen for the high call rate SNPs, an examination
of discrepancy by source of the genotype call yields a
much different picture. As indicated in Table 2, for the
463 sequenced individuals, approximately 99.1% of the
genotype calls in the GENO file were sequence reads.
When we compare these sequence calls with the GWAS
chip calls, we see a low discrepancy rate overall (0.06%).
Although this is twice the rate found for the high call
rate SNPs, it still strongly supports the supposition that
both the sequencing calls and the genotype chip calls
are highly reliable. However, attempting to impute the
last 0.9% yielded a high discrepancy rate of 28.8%,
slightly higher than the 25.2% rate found for the high
call rate SNPs. An analysis of these discrepancies yields
some interesting results. As was true for the smaller
SNP set, the majority of these discrepancies (98.6%)
consisted of a homozygote call from the GWAS chip
and a heterozygote call from the imputation. In all of
these cases as well, the evidence suggests that there was
no ambiguity in any of these calls.
Discrepancies in the nonsequenced individuals

Not surprisingly, we see higher discrepancy rates in individuals whose sequence was inferred than in the sequenced
individuals themselves. Having no sequenced family members clearly degraded the process further: the discrepancy
rate for inferred individuals without genotyped family
members was approximately twice the rate of discrepancies found in individuals with sequenced family members
(Table 2, final two rows). A breakdown of the discrepancy
rate by family and sequenced versus inferred family
members is provided in Table 1.

Discussion and conclusions
Our ability to critique the overall imputation and inference
process was limited by the absence of imputation quality
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measures in the distributed data. For the reasons noted,
we believe that only unambiguous imputation calls were
included in the data. Almost all of the discrepancies
between imputed and GWAS chip genotypes in sequenced
individuals involved heterozygous imputation calls. Even
though future researchers may be unlikely to follow this
exact method, we believe our results highlight several
generally applicable points: First, this is a cautionary
paper. The highly skilled providers of the GAW18 data, in
collaboration with one of the founders of the field of
genetic imputation, provided data to the GAW participants that were unreliable in some places. Clearly, evaluating imputation quality is critical when using imputed data.
However, the standard quality scores provided by the
imputation programs, such as the allelic R2 [6] do not take
chance agreement into account, which is particularly problematic for rare variants. Nonetheless, the IQS [7], which
does takes chance agreement into account, is still not as
widely used as might be warranted. Although a straightforward application of the IQS requires true genotypes for
comparison, multiple approximations have been suggested
(e.g., [8]).
Because of the complex imputation and inference
method used by the GAW18 data providers, it is unclear
at what point the discrepant heterozygotes were introduced into the process. It may be that these were introduced by Merlin when calculating the probabilities of
each possible genotype for missing data in the complete
pedigrees. If this is the case, then a heterozygote may be
computationally very likely: a pair of heterozygous founders is completely compatible with all possible offspring
genotypes; deviations from Hardy-Weinberg (caused by
the Wahlund effect, for example) may cause expected
heterozygosity to be higher than observed; and in the
case of deletions, the apparent genotyping errors that
can occur from the transmission of the “null” allele can
be resolved by assuming that the parent is, in fact, a
heterozygote. It may be better to allow missing sequence
data to remain missing and accept the inference of missing genotypes on related individuals than to use highly
likely genotypes inferred from the pedigree data. This
may be especially important when studying rare variants
because a modest number of inferred heterozygous
founders could greatly influence transmission tests.
Despite these cautions, we see clearly that the process
of sequencing some individuals and inferring genotypes
for related individuals produces high-quality data; this
provides a very good first step in filling the gap until
complete data are available. The inference process is
less robust when using sequence data from unrelated
individuals.
Overall, the inference and imputation process worked
very well. It is clear that GWAS chip data can be phased
with high accuracy and sequence data can be inferred
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with high concordance to the GWAS chip genotypes.
There are three conclusions from our investigation: (a)
there is a very high concordance rate between genotypes
obtained from sequencing and those from a GWAS array.
(b) When sequencing results in missing genotypes, it may
be best to retain the missingness. If sequencing failed in a
region because of abnormalities such as deletions, the
imputation process may not have appropriate reference
data to work with. This is especially true in the case of
rare variants, with which incorrectly imputing a heterozygote may reduce the power or create false positives for
transmission disequilibrium tests. (c) The imputation and
inference process may result in final data that is discrepant
from the original GWAS data. As a consequence, it may
be prudent to incorporate the GWAS chip genotype calls
into the final data set used for analysis (e.g., blanking
discrepant genotypes).
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